Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors
- 1 January 2002
- journal article
- Published by Wiley in Transfusion
- Vol. 42 (1) , 4-9
- https://doi.org/10.1046/j.1537-2995.2002.00010.x
Abstract
BACKGROUND: Predictive factors of the response to rHuG–CSF in normal donors have not been extensively studied. STUDY DESIGN AND METHODS: We analyzed factors influencing CD34+ cell yield in the 1st day of collection in 261 healthy donors from the Spanish National Donor Registry. The median age was 38 years (range, 2‐72). The median dose of rHuG–CSF was 10 μg per kg per day (range, 5‐20) over 4 days. In 103 donors (40%), 6 per kg CD34+ cells were collected. The variables that were analyzed included age, sex, weight, basal complete blood cell count, dose, type of rHuGCSF and schedule of administration, and maximum WBC count before apheresis. RESULTS: By univariate analysis, the maximum WBC count (9/L, p = 0.004), advanced age (p = 0.008), and number of daily rHuG–CSF doses (one vs. two; p = 0.01) correlated with the number of CD34+ cells collected. By multivariate analysis, donors age (<38 vs. ≥38 years; p = 0.014) and a single daily dose of rHuG–CSF (p = 0.005) were the two variables that significantly predicted a low CD34+ cell yield. CONCLUSION: Donors' age, with a threshold of 38 years or more, and the rHuG–CSF schedule are the factors that significantly affected CD34+ cell mobilization and collection in healthy donors.Keywords
This publication has 31 references indexed in Scilit:
- A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantationBritish Journal of Haematology, 2000
- Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donorsBone Marrow Transplantation, 1999
- Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor RegistryBone Marrow Transplantation, 1999
- Blood and marrow transplantation activity in Europe 1997Bone Marrow Transplantation, 1999
- A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignanciesBone Marrow Transplantation, 1998
- Comparison between once a day vs twice a day G-CSF for mobilization of peripheral blood progenitor cells (PBPC) in normal donors for allogeneic PBPC transplantationBone Marrow Transplantation, 1998
- Not All Healthy Donors Mobilize Hematopoietic Progenitor Cells Sufficiently After G-CSF Administration to Allow for Subsequent CD34 Purification of the Leukapheresis ProductJournal of Hematotherapy, 1998
- Crossover study of the haematological effects and pharmacokinetics of glycosylated and non‐glycosylated G‐CSF in healthy volunteersBritish Journal of Haematology, 1997
- Large Volume Leukapheresis Maximizes the Progenitor Cell Yield for Allogeneic Peripheral Blood Progenitor DonationJournal of Hematotherapy, 1997
- STEM CELL MOBILIzATION IN NORMAL DONORS FOR ALLOGENEIC TRANSPLANTATION: ANALYSIS OF SAFETY AND FACTORS AFFECTING EFFICACYBritish Journal of Haematology, 1996